Literature DB >> 1323464

Cytochrome b positive X-linked chronic granulomatous disease: a normal cell surface expression of cytochrome b.

H Azuma1, H Oomi, D Ueda, K Sasaki, Y Makita, K Tomizawa, Y Sakiyama, K Fujita, H Yoshioka, A Okuno.   

Abstract

The polymorphonuclear (PMN) cells from a patient with cytochrome b positive X-linked chronic granulomatous disease (Xb+ CGD) were studied using flow cytometry. Both the cell surface expression of monoclonal antibody defined cytochrome b and the superoxide production (intracellular 2',7'-Dichlorofluorescin Diacetate oxidation) were investigated at a single cell level. Flow cytometry clearly demonstrated the complete absence of superoxide production in the patient's PMN cells, the mosaicism in his mother's PMN cells and also indicated the normal cell surface expression of cytochrome b. The results obtained by Western blot analysis and reduced-minus-oxidized spectra confirmed the presence of functional and normal amounts of cytochrome b. We concluded that this is a case of Xb+ CGD with a normal cell surface expression of cytochrome b.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323464     DOI: 10.1007/bf02072229

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b.

Authors:  C A Parkos; M C Dinauer; L E Walker; R A Allen; A J Jesaitis; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  The quaternary structure of the plasma membrane b-type cytochrome of human granulocytes.

Authors:  C A Parkos; R A Allen; C G Cochrane; A J Jesaitis
Journal:  Biochim Biophys Acta       Date:  1988-01-20

3.  The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex.

Authors:  M C Dinauer; S H Orkin; R Brown; A J Jesaitis; C A Parkos
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

4.  Phosphorylation of the oxidase-related 48K phosphoprotein family in the unusual autosomal cytochrome-negative and X-linked cytochrome-positive types of chronic granulomatous disease.

Authors:  N Okamura; S E Malawista; R L Roberts; H Rosen; H D Ochs; B M Babior; J T Curnutte
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

5.  Gastrointestinal manifestations of chronic granulomatous disease.

Authors:  M E Ament; H D Ochs
Journal:  N Engl J Med       Date:  1973-02-22       Impact factor: 91.245

6.  The NBT slide test: a simple screening method for detecting chronic granulomatous disease and female carriers.

Authors:  H D Ochs; R P Igo
Journal:  J Pediatr       Date:  1973-07       Impact factor: 4.406

7.  Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.

Authors:  R A Clark; H L Malech; J I Gallin; H Nunoi; B D Volpp; D W Pearson; W M Nauseef; J T Curnutte
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

8.  Reevaluation of cytochrome b and flavin adenine dinucleotide in neutrophils from patients with chronic granulomatous disease and description of a family with probable autosomal recessive inheritance of cytochrome b deficiency.

Authors:  Y Ohno; E S Buescher; R Roberts; J A Metcalf; J I Gallin
Journal:  Blood       Date:  1986-04       Impact factor: 22.113

Review 9.  The respiratory burst oxidase.

Authors:  B M Babior
Journal:  Hematol Oncol Clin North Am       Date:  1988-06       Impact factor: 3.722

10.  Classification of chronic granulomatous disease.

Authors:  J T Curnutte
Journal:  Hematol Oncol Clin North Am       Date:  1988-06       Impact factor: 3.722

View more
  1 in total

1.  Variant Type X91+ Chronic Granulomatous Disease: Clinical and Molecular Characterization in a Chinese Cohort.

Authors:  Bijun Sun; Zeyu Zhu; Xiaoying Hui; Jinqiao Sun; Wenjie Wang; Wenjing Ying; Qinhua Zhou; Haili Yao; Jia Hou; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2022-07-07       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.